Karyopharm appoints michael mano as senior vice president, general counsel and reports inducement grants under nasdaq listing rule 5635(c)(4)

Newton, mass., dec. 15, 2020 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of michael mano as senior vice president, general counsel. mr. mano brings over 15 years...
KPTI Ratings Summary
KPTI Quant Ranking